Neurotez Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Neurotez Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10807
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Neurotez Inc (Neurotez) is a biotechnology company that develops and markets leptin product, a novel hormone replacement therapy for Alzheimer’s disease (AD). The company’s product pipeline includes leptin, NT1, NT2, and others. Its product leptin is an adipocyte hormone that controls energy homeostasis and is used for the treatment of Alzheimer’s disease. Neurotez also develops a novel protein-protein interaction in a subset of familial cases of early onset Alzheimer’s disease and discovers CNS drugs. The company uses the screening methodology to identify the protein-protein interactions and novel protein targets for the drug development. Neurotez is headquartered in Bridgewater, New Jersey, the US.

Neurotez Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Neurotez Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Neurotez Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Neurotez Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Neurotez Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Neurotez Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Neurotez Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Neurotez Partners with KineMed 10
Licensing Agreements 11
Neurotez Enters into Licensing Agreement with GCA Therapeutics to Develop Leptin Derivatives 11
Equity Offering 12
Neurotez to Raise up to USD7 Million in Private Placement of Shares 12
Neurotez Inc – Key Competitors 13
Neurotez Inc – Key Employees 14
Neurotez Inc – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Neurotez Inc, Pharmaceuticals & Healthcare, Key Facts 2
Neurotez Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Neurotez Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Neurotez Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Neurotez Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Neurotez Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Neurotez Partners with KineMed 10
Neurotez Enters into Licensing Agreement with GCA Therapeutics to Develop Leptin Derivatives 11
Neurotez to Raise up to USD7 Million in Private Placement of Shares 12
Neurotez Inc, Key Competitors 13
Neurotez Inc, Key Employees 14

List of Figures
Neurotez Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Neurotez Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Neurotez Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Neurotez Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Neurotez Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Neurotez Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Neurotez Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Neurotez Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Neurotez Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • B. Braun Melsungen AG:医療機器:M&Aディール及び事業提携情報
    Summary B. Braun Melsungen AG (B. Braun) develops, manufactures and distributes medical technology and pharmaceutical products, and provides medical services worldwide. The company’s major products include solutions and disposables for infusion, nutrition and pain therapy, infusion pumps and systems …
  • Sunstar Holding AG:企業の戦略・SWOT・財務情報
    Sunstar Holding AG - Strategy, SWOT and Corporate Finance Report Summary Sunstar Holding AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Stryker Corporation:企業のM&A・事業提携・投資動向
    Stryker Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Stryker Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • China Railway Group Ltd:戦略・SWOT・企業財務分析
    China Railway Group Ltd - Strategy, SWOT and Corporate Finance Report Summary China Railway Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • China National Building Material Co Ltd:企業のM&A・事業提携・投資動向
    China National Building Material Co Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's China National Building Material Co Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed re …
  • Profarma Distribuidora de Produtos Farmaceuticos SA (PFRM3):企業の財務・戦略的SWOT分析
    Profarma Distribuidora de Produtos Farmaceuticos SA (PFRM3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the comp …
  • Veracyte Inc (VCYT):企業の財務・戦略的SWOT分析
    Summary Veracyte Inc (Veracyte) is a molecular diagnostics company that uses genomic technology to resolve diagnostic ambiguity. The company’s pipeline products comprise Afirma thyroid FNA analysis for the diagnosis of thyroid cancer based on its proprietary afirma gene expression classifier. It als …
  • Electrica SA (EL):電力:M&Aディール及び事業提携情報
    Summary Electrica SA (Electrica) is a power utility that distributes and supplies electricity. Its services include electricity supply, distribution, and trading, and power distribution networks operations and management, and design and consultation for aerial and subterranean power networks. It als …
  • Day & Zimmermann Group, Inc.:戦略・SWOT・企業財務分析
    Day & Zimmermann Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Day & Zimmermann Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Vision International People Group Public Limited:戦略・SWOT・企業財務分析
    Vision International People Group Public Limited - Strategy, SWOT and Corporate Finance Report Summary Vision International People Group Public Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, …
  • Arbutus Biopharma Corp (ABUS):企業の財務・戦略的SWOT分析
    Arbutus Biopharma Corp (ABUS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Independence Group NL:企業のM&A・事業提携・投資動向
    Independence Group NL - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Independence Group NL Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • CDW Corporation:戦略・SWOT・企業財務分析
    CDW Corporation - Strategy, SWOT and Corporate Finance Report Summary CDW Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Unipetrol, a.s. (UNIPE):石油・ガス:M&Aディール及び事業提携情報
    Summary Unipetrol AS (Unipetrol), a subsidiary of Polski Koncern Naftowy Orlen SA, is refinery and petrochemical company. The company produces and sells petroleum products, petrochemicals, plastics and specialty chemicals. Unipetrol owns and operates transport services, filling stations and carries …
  • NovoCure Ltd (NVCR)-医療機器分野:企業M&A・提携分析
    Summary NovoCure Ltd (NovoCure) is an drug company that concentrates on the development and commercialization of novel therapies for tumor treating fields. The company’s pipeline products find application in various types of cancer indications such as ovarian cancer, malignant melanoma, hepatocellul …
  • The Armstrong Bros. Tool Co.:企業の戦略的SWOT分析
    The Armstrong Bros. Tool Co. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Keyera Corp (KEY):石油・ガス:M&Aディール及び事業提携情報
    Summary Keyera Corp (Keyera) is a midstream oil and gas company. The company offers services such as processing, storage, transportation and marketing of oil and natural gas. It owns and operates raw gas gathering pipelines and processing plants, which collect and process raw natural gas, remove was …
  • MDU Resources Group, Inc.:企業の戦略・SWOT・財務分析
    MDU Resources Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary MDU Resources Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • GS Yuasa Corporation:企業の戦略・SWOT・財務分析
    GS Yuasa Corporation - Strategy, SWOT and Corporate Finance Report Summary GS Yuasa Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Coslight Technology International Group Ltd (1043):企業の財務・戦略的SWOT分析
    Coslight Technology International Group Ltd (1043) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆